DEUTSCHE BANK AG\ - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$4,146,515
-16.7%
82,567
+4.8%
0.00%0.0%
Q2 2023$4,977,758
+3.4%
78,762
-26.4%
0.00%0.0%
Q1 2023$4,814,290
+29.0%
107,008
+25.6%
0.00%
+50.0%
Q4 2022$3,733,357
-69.4%
85,217
-54.0%
0.00%
-71.4%
Q3 2022$12,217,000
+24.3%
185,412
-4.7%
0.01%
+40.0%
Q2 2022$9,831,000
-22.3%
194,641
-1.7%
0.01%
-16.7%
Q1 2022$12,652,000
-41.4%
198,067
-1.7%
0.01%
-40.0%
Q4 2021$21,581,000
-51.0%
201,485
-52.9%
0.01%
-52.4%
Q3 2021$44,006,000
+15.8%
428,028
-0.9%
0.02%
+16.7%
Q2 2021$37,989,000
+5.6%
431,888
+16.7%
0.02%
-5.3%
Q1 2021$35,981,000
-24.2%
370,056
-12.6%
0.02%
-34.5%
Q4 2020$47,478,000
+20.2%
423,351
-0.6%
0.03%
+7.4%
Q3 2020$39,484,000
+4.7%
425,940
-11.9%
0.03%
-6.9%
Q2 2020$37,700,000
+83.7%
483,337
+37.7%
0.03%
+61.1%
Q1 2020$20,525,000
-13.3%
350,963
+18.8%
0.02%
+20.0%
Q4 2019$23,665,000
+6.6%
295,426
-2.2%
0.02%0.0%
Q3 2019$22,196,000
-24.3%
302,128
-2.8%
0.02%
-11.8%
Q2 2019$29,325,000
+126.0%
310,910
+91.8%
0.02%
+112.5%
Q1 2019$12,974,000
+61.6%
162,099
+8.8%
0.01%
+33.3%
Q4 2018$8,029,000
-70.4%
148,957
-57.1%
0.01%
-25.0%
Q3 2018$27,083,000
-46.0%
346,967
-56.1%
0.01%
-42.9%
Q2 2018$50,138,000
+254.8%
789,860
+412.5%
0.01%
+100.0%
Q1 2018$14,131,000
+65.5%
154,122
+36.1%
0.01%
+40.0%
Q4 2017$8,540,000
+118.4%
113,282
+101.6%
0.01%
+66.7%
Q3 2017$3,911,000
-5.8%
56,180
-31.5%
0.00%0.0%
Q2 2017$4,150,000
+175.2%
81,989
+116.9%
0.00%
+200.0%
Q1 2017$1,508,000
+104.6%
37,798
+43.2%
0.00%0.0%
Q4 2016$737,000
-31.3%
26,403
-27.1%
0.00%0.0%
Q3 2016$1,073,000
-20.4%
36,231
-45.7%
0.00%0.0%
Q2 2016$1,348,000
+14.8%
66,716
+2.4%
0.00%0.0%
Q1 2016$1,174,000
-62.3%
65,165
-44.9%
0.00%
-50.0%
Q4 2015$3,112,000
-20.7%
118,247
-35.7%
0.00%
-33.3%
Q3 2015$3,924,000
+2663.4%
183,971
+3299.9%
0.00%
Q2 2015$142,0005,4110.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders